EDN1 and retinitis pigmentosa 1: This phenomenon is illustrated biologically by the upregulation of vasoconstrictive endothelin-1 (ET-1) [44] and altered endothelial nitric oxide (NO) metabolism [45], and it is clinically expressed by Raynaud’s phenomenon (RP) attacks.